| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| MDT - Medtronic PLC | BUY | 711 @ USD 98.63 | USD 70,126 | The ETF bought 711 new shares of MDT (Medtronic PLC). The shares were bought for an average price of 98.63 compared to the previous average buy price of 89.4904. This is 10.2% higher than average price of previous purchases of MDT. |
| BSX - Boston Scientific Corporation | BUY | 704 @ USD 95.61 | USD 67,309 | The ETF bought 704 new shares of BSX (Boston Scientific Corporation). The shares were bought for an average price of 95.61 compared to the previous average buy price of 98.196. This is -2.6% lower than average price of previous purchases of BSX. |
| BSX - MULSTRXSSXIMETFP | BUY | 704 @ USD 95.61 | USD 67,309 | The ETF bought 704 new shares of BSX (MULSTRXSSXIMETFP). The shares were bought for an average price of 95.61 compared to the previous average buy price of 98.196. This is -2.6% lower than average price of previous purchases of BSX. |
| ABT - Abbott Laboratories | BUY | 496 @ USD 125.45 | USD 62,223 | The ETF bought 496 new shares of ABT (Abbott Laboratories). The shares were bought for an average price of 125.45 compared to the previous average buy price of 128.644. This is -2.5% lower than average price of previous purchases of ABT. |
| SYK - Stryker Corporation | BUY | 157 @ USD 355.2 | USD 55,766 | The ETF bought 157 new shares of SYK (Stryker Corporation). The shares were bought for an average price of 355.2 compared to the previous average buy price of 374.8. This is -5.2% lower than average price of previous purchases of SYK. |
| BDX - Becton Dickinson and Company | BUY | 118 @ USD 195.59 | USD 23,080 | The ETF bought 118 new shares of BDX (Becton Dickinson and Company). The shares were bought for an average price of 195.59 compared to the previous average buy price of 201.916. This is -3.1% lower than average price of previous purchases of BDX. |
| GKOS - Glaukos Corp | BUY | 122 @ USD 116.22 | USD 14,179 | The ETF bought 122 new shares of GKOS (Glaukos Corp). The shares were bought for an average price of 116.22 compared to the previous average buy price of 106.937. This is 8.7% higher than average price of previous purchases of GKOS. |
| HOLX - Hologic Inc | BUY | 183 @ USD 74.95 | USD 13,716 | The ETF bought 183 new shares of HOLX (Hologic Inc). The shares were bought for an average price of 74.95 compared to the previous average buy price of 67.0007. This is 11.9% higher than average price of previous purchases of HOLX. |
| OFIX - Orthofix Medical Inc | BUY | 885 @ USD 15.4599 | USD 13,682 | The ETF bought 885 new shares of OFIX (Orthofix Medical Inc). The shares were bought for an average price of 15.4599 compared to the previous average buy price of 15.4031. This is 0.4% higher than average price of previous purchases of OFIX. |
| LIVN - LivaNova PLC | BUY | 217 @ USD 62.82 | USD 13,632 | The ETF bought 217 new shares of LIVN (LivaNova PLC). The shares were bought for an average price of 62.82 compared to the previous average buy price of 46.7757. This is 34.3% higher than average price of previous purchases of LIVN. |
| BAX - Baxter International Inc | BUY | 711 @ USD 18.96 | USD 13,481 | The ETF bought 711 new shares of BAX (Baxter International Inc). The shares were bought for an average price of 18.96 compared to the previous average buy price of 27.4613. This is -31.0% lower than average price of previous purchases of BAX. |
| RMD - ResMed Inc | HOLD | 0 @ USD 244.94 | USD 0 | The current share valuation price of RMD based on adjusted close was USD 244.94. The average price that RMD shares were previous bought at was USD 244.874. The current market price is 0.0% higher than average price they were purchased at. The value of the holding in RMD has increased by USD 48,044 compared to the previous valuation of ResMed Inc however if the holding was sold on 2025-12-19 this would crystalise an overall loss. |
| NVCR - Novocure Ltd | HOLD | 0 @ USD 12.84 | USD 0 | The current share valuation price of NVCR based on adjusted close was USD 12.84. The average price that NVCR shares were previous bought at was USD 17.8097. The current market price is -27.9% lower than average price they were purchased at. The value of the holding in NVCR has increased by USD 3,912 compared to the previous valuation of Novocure Ltd however if the holding was sold on 2025-12-19 this would crystalise an overall loss. |
| PEN - Pennant International Group plc | HOLD | 0 @ USD 315.9 | USD 0 | The current share valuation price of PEN based on adjusted close was USD 315.9. The average price that PEN shares were previous bought at was USD 259.671. The current market price is 21.7% higher than average price they were purchased at. The value of the holding in PEN has increased by USD 2,953 compared to the previous valuation of Pennant International Group plc however if the holding was sold on 2025-12-19 this would crystalise an overall loss. |
| PEN - PBF Energy Inc | HOLD | 0 @ USD 315.9 | USD 0 | The current share valuation price of PEN based on adjusted close was USD 315.9. The average price that PEN shares were previous bought at was USD 259.671. The current market price is 21.7% higher than average price they were purchased at. The value of the holding in PEN has increased by USD 2,953 compared to the previous valuation of PBF Energy Inc however if the holding was sold on 2025-12-19 this would crystalise an overall loss. |
| PODD - Insulet Corporation | HOLD | 0 @ USD 289.62 | USD 0 | The current share valuation price of PODD based on adjusted close was USD 289.62. The average price that PODD shares were previous bought at was USD 293.253. The current market price is -1.2% lower than average price they were purchased at. The value of the holding in PODD has fallen by USD 31,485 compared to the previous valuation of Insulet Corporation |
| PRCT - Procept Biorobotics Corp | HOLD | 0 @ USD 32.06 | USD 0 | The current share valuation price of PRCT based on adjusted close was USD 32.06. The average price that PRCT shares were previous bought at was USD 59.3385. The current market price is -46.0% lower than average price they were purchased at. The value of the holding in PRCT has fallen by USD 5,084 compared to the previous valuation of Procept Biorobotics Corp |
| QDEL - Quidel Corporation | HOLD | 0 @ USD 28.95 | USD 0 | The current share valuation price of QDEL based on adjusted close was USD 28.95. The average price that QDEL shares were previous bought at was USD 34.337. The current market price is -15.7% lower than average price they were purchased at. The value of the holding in QDEL has increased by USD 5,907 compared to the previous valuation of Quidel Corporation however if the holding was sold on 2025-12-19 this would crystalise an overall loss. |
| ITGR - Integer Holdings Corp | HOLD | 0 @ USD 78.5801 | USD 0 | The current share valuation price of ITGR based on adjusted close was USD 78.5801. The average price that ITGR shares were previous bought at was USD 117.637. The current market price is -33.2% lower than average price they were purchased at. The value of the holding in ITGR has increased by USD 287 compared to the previous valuation of Integer Holdings Corp however if the holding was sold on 2025-12-19 this would crystalise an overall loss. |
| SIBN - Si-Bone Inc | HOLD | 0 @ USD 20.3801 | USD 0 | The current share valuation price of SIBN based on adjusted close was USD 20.3801. The average price that SIBN shares were previous bought at was USD 15.3583. The current market price is 32.7% higher than average price they were purchased at. The value of the holding in SIBN has increased by USD 651 compared to the previous valuation of Si-Bone Inc however if the holding was sold on 2025-12-19 this would crystalise an overall loss. |
| STE - STERIS plc | HOLD | 0 @ USD 254.34 | USD 0 | The current share valuation price of STE based on adjusted close was USD 254.34. The average price that STE shares were previous bought at was USD 229.731. The current market price is 10.7% higher than average price they were purchased at. The value of the holding in STE has increased by USD 37,621 compared to the previous valuation of STERIS plc however if the holding was sold on 2025-12-19 this would crystalise an overall loss. |
| TFX - Teleflex Incorporated | HOLD | 0 @ USD 121.89 | USD 0 | The current share valuation price of TFX based on adjusted close was USD 121.89. The average price that TFX shares were previous bought at was USD 142.319. The current market price is -14.4% lower than average price they were purchased at. The value of the holding in TFX has fallen by USD 15,785 compared to the previous valuation of Teleflex Incorporated |
| TMDX - TransMedics Group Inc | HOLD | 0 @ USD 127.67 | USD 0 | The current share valuation price of TMDX based on adjusted close was USD 127.67. The average price that TMDX shares were previous bought at was USD 93.1357. The current market price is 37.1% higher than average price they were purchased at. The value of the holding in TMDX has increased by USD 30,802 compared to the previous valuation of TransMedics Group Inc however if the holding was sold on 2025-12-19 this would crystalise an overall loss. |
| TNDM - Tandem Diabetes Care Inc | HOLD | 0 @ USD 22.07 | USD 0 | The current share valuation price of TNDM based on adjusted close was USD 22.07. The average price that TNDM shares were previous bought at was USD 20.954. The current market price is 5.3% higher than average price they were purchased at. The value of the holding in TNDM has increased by USD 2,571 compared to the previous valuation of Tandem Diabetes Care Inc however if the holding was sold on 2025-12-19 this would crystalise an overall loss. |
| VREX - Varex Imaging Corp | HOLD | 0 @ USD 12.2899 | USD 0 | The current share valuation price of VREX based on adjusted close was USD 12.2899. The average price that VREX shares were previous bought at was USD 11.354. The current market price is 8.2% higher than average price they were purchased at. The value of the holding in VREX has fallen by USD 218 compared to the previous valuation of Varex Imaging Corp |
| ZBH - Zimmer Biomet Holdings Inc | HOLD | 0 @ USD 89.13 | USD 0 | The current share valuation price of ZBH based on adjusted close was USD 89.13. The average price that ZBH shares were previous bought at was USD 102.164. The current market price is -12.8% lower than average price they were purchased at. The value of the holding in ZBH has fallen by USD 34,589 compared to the previous valuation of Zimmer Biomet Holdings Inc |
| LMAT - LeMaitre Vascular Inc | HOLD | 0 @ USD 84.9601 | USD 0 | The current share valuation price of LMAT based on adjusted close was USD 84.9601. The average price that LMAT shares were previous bought at was USD 88.5551. The current market price is -4.1% lower than average price they were purchased at. The value of the holding in LMAT has fallen by USD 901 compared to the previous valuation of LeMaitre Vascular Inc |
| AORT - Artivion Inc | HOLD | 0 @ USD 46.5501 | USD 0 | The current share valuation price of AORT based on adjusted close was USD 46.5501. The average price that AORT shares were previous bought at was USD 34.7351. The current market price is 34.0% higher than average price they were purchased at. The value of the holding in AORT has fallen by USD 3,409 compared to the previous valuation of Artivion Inc |
| ATEC - Alphatec Holdings Inc | HOLD | 0 @ USD 20.01 | USD 0 | The current share valuation price of ATEC based on adjusted close was USD 20.01. The average price that ATEC shares were previous bought at was USD 13.2192. The current market price is 51.4% higher than average price they were purchased at. The value of the holding in ATEC has increased by USD 2,184 compared to the previous valuation of Alphatec Holdings Inc however if the holding was sold on 2025-12-19 this would crystalise an overall loss. |
| ATRC - AtriCure Inc | HOLD | 0 @ USD 40.9501 | USD 0 | The current share valuation price of ATRC based on adjusted close was USD 40.9501. The average price that ATRC shares were previous bought at was USD 35.4391. The current market price is 15.6% higher than average price they were purchased at. The value of the holding in ATRC has increased by USD 3,734 compared to the previous valuation of AtriCure Inc however if the holding was sold on 2025-12-19 this would crystalise an overall loss. |
| AXGN - Axogen Inc | HOLD | 0 @ USD 31.98 | USD 0 | The current share valuation price of AXGN based on adjusted close was USD 31.98. The average price that AXGN shares were previous bought at was USD 18.2722. The current market price is 75.0% higher than average price they were purchased at. The value of the holding in AXGN has increased by USD 1,816 compared to the previous valuation of Axogen Inc however if the holding was sold on 2025-12-19 this would crystalise an overall loss. |
| CNMD - CONMED Corporation | HOLD | 0 @ USD 39.9499 | USD 0 | The current share valuation price of CNMD based on adjusted close was USD 39.9499. The average price that CNMD shares were previous bought at was USD 56.641. The current market price is -29.5% lower than average price they were purchased at. The value of the holding in CNMD has fallen by USD 1,845 compared to the previous valuation of CONMED Corporation |
| DXCM - DexCom Inc | HOLD | 0 @ USD 66.06 | USD 0 | The current share valuation price of DXCM based on adjusted close was USD 66.06. The average price that DXCM shares were previous bought at was USD 75.1618. The current market price is -12.1% lower than average price they were purchased at. The value of the holding in DXCM has increased by USD 8,052 compared to the previous valuation of DexCom Inc however if the holding was sold on 2025-12-19 this would crystalise an overall loss. |
| ENOV - Enovis Corp | HOLD | 0 @ USD 26.76 | USD 0 | The current share valuation price of ENOV based on adjusted close was USD 26.76. The average price that ENOV shares were previous bought at was USD 36.4594. The current market price is -26.6% lower than average price they were purchased at. The value of the holding in ENOV has fallen by USD 4,442 compared to the previous valuation of Enovis Corp |
| GEHC - GE HealthCare Technologies Inc. | HOLD | 0 @ USD 82.89 | USD 0 | The current share valuation price of GEHC based on adjusted close was USD 82.89. The average price that GEHC shares were previous bought at was USD 74.8934. The current market price is 10.7% higher than average price they were purchased at. The value of the holding in GEHC has increased by USD 23,196 compared to the previous valuation of GE HealthCare Technologies Inc. however if the holding was sold on 2025-12-19 this would crystalise an overall loss. |
| IART - Integra LifeSciences Holdings | HOLD | 0 @ USD 12.65 | USD 0 | The current share valuation price of IART based on adjusted close was USD 12.65. The average price that IART shares were previous bought at was USD 17.8768. The current market price is -29.2% lower than average price they were purchased at. The value of the holding in IART has fallen by USD 3,650 compared to the previous valuation of Integra LifeSciences Holdings |
| IDXX - IDEXX Laboratories Inc | HOLD | 0 @ USD 700.34 | USD 0 | The current share valuation price of IDXX based on adjusted close was USD 700.34. The average price that IDXX shares were previous bought at was USD 509.311. The current market price is 37.5% higher than average price they were purchased at. The value of the holding in IDXX has increased by USD 35,553 compared to the previous valuation of IDEXX Laboratories Inc however if the holding was sold on 2025-12-19 this would crystalise an overall loss. |
| INSP - Inspirit Energy Holdings Plc | HOLD | 0 @ USD 96.54 | USD 0 | The current share valuation price of INSP based on adjusted close was USD 96.54. The average price that INSP shares were previous bought at was USD 135.25. The current market price is -28.6% lower than average price they were purchased at. The value of the holding in INSP has increased by USD 4,678 compared to the previous valuation of Inspirit Energy Holdings Plc however if the holding was sold on 2025-12-19 this would crystalise an overall loss. |
| IRTC - iRhythm Technologies Inc | HOLD | 0 @ USD 174.17 | USD 0 | The current share valuation price of IRTC based on adjusted close was USD 174.17. The average price that IRTC shares were previous bought at was USD 129.4. The current market price is 34.6% higher than average price they were purchased at. The value of the holding in IRTC has increased by USD 25,093 compared to the previous valuation of iRhythm Technologies Inc however if the holding was sold on 2025-12-19 this would crystalise an overall loss. |
| MASI - Masimo Corporation | HOLD | 0 @ USD 134.04 | USD 0 | The current share valuation price of MASI based on adjusted close was USD 134.04. The average price that MASI shares were previous bought at was USD 154.973. The current market price is -13.5% lower than average price they were purchased at. The value of the holding in MASI has fallen by USD 16,564 compared to the previous valuation of Masimo Corporation |
| NVST - Envista Holdings Corp | SELL | -628 @ USD 22.28 | USD -13,992 | The ETF sold 628 shares of NVST on 2025-12-19. The shares were previously bought for an average price of USD 19.1276. The Envista Holdings Corp shares were sold for 16.5% higher than average price of previous purchases. This sale made a profit of USD 1,980 The average price that the ETF previously sold NVST share for is USD 20.0082 so the ETF has sold 628 shares on 2025-12-19 at a higher price than the previous selling average. |
| OMCL - Omnicell Inc | SELL | -300 @ USD 46.84 | USD -14,052 | The ETF sold 300 shares of OMCL on 2025-12-19. The shares were previously bought for an average price of USD 34.6291. The Omnicell Inc shares were sold for 35.3% higher than average price of previous purchases. This sale made a profit of USD 3,663 The average price that the ETF previously sold OMCL share for is USD 37.6795 so the ETF has sold 300 shares on 2025-12-19 at a higher price than the previous selling average. |
| GMED - Globus Medical | SELL | -168 @ USD 87.06 | USD -14,626 | The ETF sold 168 shares of GMED on 2025-12-19. The shares were previously bought for an average price of USD 70.2905. The Globus Medical shares were sold for 23.9% higher than average price of previous purchases. This sale made a profit of USD 2,817 The average price that the ETF previously sold GMED share for is USD 71.8014 so the ETF has sold 168 shares on 2025-12-19 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -657 @ USD 85.66 | USD -56,279 | The ETF sold 657 shares of EW on 2025-12-19. The shares were previously bought for an average price of USD 73.2429. The Edwards Lifesciences Corp shares were sold for 17.0% higher than average price of previous purchases. This sale made a profit of USD 8,158 The average price that the ETF previously sold EW share for is USD 74.2978 so the ETF has sold 657 shares on 2025-12-19 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -400 @ USD 572.47 | USD -228,988 | The ETF sold 400 shares of ISRG on 2025-12-19. The shares were previously bought for an average price of USD 510.011. The Intuitive Surgical Inc shares were sold for 12.2% higher than average price of previous purchases. This sale made a profit of USD 24,984 The average price that the ETF previously sold ISRG share for is USD 530.772 so the ETF has sold 400 shares on 2025-12-19 at a higher price than the previous selling average. |